Pulmotect's Grant

Pulmotect raised a round of funding on June 15, 2009. Investors include Texas Emerging Technology Fund.

Pulmotect is a bio-pharmaceutical company that develops products (host-directed/pathogen-agnostic) to reduce morbidity and mortality in patients at risk of severe respiratory diseases.…

Articles about Pulmotect's Grant: